España – Productos farmacéuticos – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib

This tender is a framework agreement for the aggregated supply of specific pharmaceutical medicines, including Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab and Pazopanib. The buyer is the Institut Català de la Salut, located in Spain. The contract also covers several participating medical centers: Hospital del Mar in Barcelona, Sant Joan de Reus-Baix Camp, Hospital de Cerdanya, and the Institut d'Assistència Sanitària. The provided description does not include information about the estimated contract value, the submission deadline, or the specific bidding procedure. Small businesses should consult the original tender documents to find eligibility criteria and application details.

Description

8 open tenders right now

• España – Reactivos de laboratorio – Suministro de reactivos e instrumentación de Hemostasia para el Hospital Universitari Vall d'Hebron 14 Jul 2026 · 4 days left
• España – Catéteres – 1101471697 Catèters i sondes per a urologia i urodinamia 16 Jul 2026 · 6 days left
• España – Medicamentos diversos – 1101472346: Medicamentos: empresas distribuidoras 17 Jul 2026 · 7 days left

Recent awards

• España – Servicios de programación de software de aplicación – 1101461218 Docenstrack

  awarded to Tecnologias Plexus, SL · €525,000

• España – Implantes quirúrgicos – 1101463976: implantes quirúrgicos neurológicos (complementario)

  awarded to SUMINISTROS HOSPITALARIOS, S.A.; SANGÜESA; PRIM, SA